Skip to main content

Table 1 Preoperative characteristics of 188 patients with clinically high-risk localized and locally advanced prostate cancer

From: Robot-assisted radical prostatectomy in the treatment of patients with clinically high-risk localized and locally advanced prostate cancer: single surgeons functional and oncologic outcomes

Parameters N = 188
Age, median (IQR), year 62.5 (51.0–79.0)
BMI, median (IQR), kg/m2 25.4 (23.6–29.5)
ASA score, median (IQR) 2.0 (1.0–2.0)
PSA, median (IQR), ng/ml 28.85 (11.5–150.8)
Prostate volume, median (IQR), cc 38.6 (23.5–110.0)
Biopsy Gleason score  
 6 4 (2.1%)
 7 58 (30.9%)
 8 82 (43.6%)
 ≥ 9 44 (23.4%)
Clinical stage  
 High-risk localized (≤ cT2c) 54 (28.7%)
 High-risk locally advanced 134 (71.3%)
  cT3a 72 (38.3%)
  ≥ cT3b 62 (33.0%)
  cN1 10 (5.3%)
SHIM score, median (IQR) 16.5 (7–24)
IPSS score, median (IQR) 14.5 (4–28)
Charlson comorbidity index  
 0 148 (78.7%)
 1–2 35 (18.6%)
  ≥ 3 5 (2.7%)